Novel compositions for preventing and treating neurodegenerative and blood coagulation disorders

Details for Australian Patent Application No. 2006204699 (hide)

Owner Sirtris Pharmaceuticals, Inc.

Inventors Normington, Karl D.; Westphal, Christopher H.; Milne, Jill; Fujii, Jennifer; Dipp, Michelle; Milburn, Michael; Elliot, Peter

Agent Shelston IP

Pub. Number AU-B-2006204699

PCT Pub. Number WO2006/076681

Priority 60/753,606 23.12.05 US; 60/692,785 22.06.05 US; 60/736,528 14.11.05 US; 60/667,179 30.03.05 US; 60/643,921 13.01.05 US

Filing date 13 January 2006

Wipo publication date 20 July 2006

Acceptance publication date 26 April 2012

International Classifications

A61K 31/065 (2006.01)

A61K 31/353 (2006.01)

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

Event Publications

23 August 2007 PCT application entered the National Phase

  PCT publication WO2006/076681 Priority application(s): WO2006/076681

26 April 2012 Application Accepted

  Published as AU-B-2006204699

23 August 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006204705-ELISA assays using prion-specific peptide reagents

2006204697-Compositions and methods for protein design